| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/19/2006 | US7150869 Gene therapy; cytokine complex; anticancer agent |
| 12/19/2006 | CA2297547C An improved method for preparing dna from serum and plasma |
| 12/19/2006 | CA2251169C Quaternary cytofectins |
| 12/19/2006 | CA2200423C Novel estrogen receptor |
| 12/19/2006 | CA2194761C Immunomodulatory oligonucleotides |
| 12/19/2006 | CA2145064C Improvements in or relating to immune response modification |
| 12/19/2006 | CA2128050C Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 12/19/2006 | CA2055447C Biosynthesis of carotenoids in genetically engineered hosts |
| 12/17/2006 | CA2548674A1 Shuttle vector and its use in the evaluation of a mutation phenomenon |
| 12/17/2006 | CA2508447A1 Shuttle vector and its use in the evaluation of a mutation phenomenon |
| 12/16/2006 | CA2512492A1 Methods and reagents for inhibiting cell proliferation |
| 12/15/2006 | CA2548689A1 Nucleic acids for detection of listeria |
| 12/14/2006 | WO2006133441A2 Method of increasing fibre yield in cotton |
| 12/14/2006 | WO2006133257A2 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy |
| 12/14/2006 | WO2006133210A2 Mannitol induced promoter systems in bacterial host cells |
| 12/14/2006 | WO2006133182A2 Insect-specific protease recognition sequences |
| 12/14/2006 | WO2006133166A2 Nucleic acid molecules encoding sucrose synthase-like polypeptides and methods of use |
| 12/14/2006 | WO2006133148A2 Method of producing antibodies with modified fucosylation level |
| 12/14/2006 | WO2006133099A2 Sirna microbicides for preventing and treating viral diseases |
| 12/14/2006 | WO2006133079A2 Increasing perhydrolase activity in esterases and/or lipases |
| 12/14/2006 | WO2006132616A1 An endogenous regulator of rna silencing in plants |
| 12/14/2006 | WO2006132607A1 Mutant allergen(s) |
| 12/14/2006 | WO2006132606A1 Hepatic stellate cell specific promoter and uses thereof |
| 12/14/2006 | WO2006132601A1 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 |
| 12/14/2006 | WO2006132598A1 Porcine circovirus type 2 vaccines |
| 12/14/2006 | WO2006132555A1 Peramine biosynthesis |
| 12/14/2006 | WO2006132446A1 Method of manufacturing probe-immobilized carrier |
| 12/14/2006 | WO2006132406A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea |
| 12/14/2006 | WO2006132401A1 Method for evaluation of compound using rsk1 |
| 12/14/2006 | WO2006132389A1 Nucleic acid, amino acid encoded by the nucleic acid, probe comprising the nucleic acid or the amino acid, and screening method using the probe |
| 12/14/2006 | WO2006132350A1 Reporter assay using secreted luminescent enzyme |
| 12/14/2006 | WO2006132341A1 sc(Fv)2 SITE-DIRECTED MUTANT |
| 12/14/2006 | WO2006132272A1 Method for production of antibody |
| 12/14/2006 | WO2006132270A1 Herbicide-resistant gene |
| 12/14/2006 | WO2006132251A1 Prophylactic/therapeutic agent for adult t cell leukemia |
| 12/14/2006 | WO2006132248A1 Method for ubiquitination of runx |
| 12/14/2006 | WO2006132204A1 Transcription factor decoy |
| 12/14/2006 | WO2006132145A1 Process for production of l-amino acid |
| 12/14/2006 | WO2006132022A1 Simple method of detecting methylcytosine |
| 12/14/2006 | WO2006131958A1 Bitis arietans snake venom-derived trypsin inhibitor-like protein bitoran and use thereof as inhibitor of blood coagulation factor xa |
| 12/14/2006 | WO2006131953A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 12/14/2006 | WO2006131936A2 Hepatitis c virus vaccine |
| 12/14/2006 | WO2006131928A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 12/14/2006 | WO2006131750A2 Lipase polypeptide |
| 12/14/2006 | WO2006131547A1 Plants having improved growth characteristics and method for making the same |
| 12/14/2006 | WO2006131543A1 Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene |
| 12/14/2006 | WO2006131512A2 Anti-thrombotic agents |
| 12/14/2006 | WO2006131490A1 Expression cassettes for seed-preferential expression in plants |
| 12/14/2006 | WO2006131477A1 Expression cassettes for seed-preferential expression in plants |
| 12/14/2006 | WO2006131013A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 12/14/2006 | WO2006130976A1 Interfering rnas, methods for their production, and use |
| 12/14/2006 | WO2006130925A1 Genetic manipulation of clostridium difficile |
| 12/14/2006 | WO2006114470A3 Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with diseases caused by necrotrophic fungal pathogens |
| 12/14/2006 | WO2006112705A3 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure. |
| 12/14/2006 | WO2006111757A3 Animal model of vascular smooth muscle cell apoptosis |
| 12/14/2006 | WO2006111586A3 Method for the in vitro determination of the degree of methylation of the line-1 promoter |
| 12/14/2006 | WO2006108674A3 Elite event a2704-12 and methods and kits for identifying such event in biological samples |
| 12/14/2006 | WO2006103452A3 Improved nitroreductase enzymes |
| 12/14/2006 | WO2006102684A3 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
| 12/14/2006 | WO2006101810A3 Theileria parva dna vaccines |
| 12/14/2006 | WO2006100257A3 Vaccine and antibodies against parasitic nematodes |
| 12/14/2006 | WO2006094673A3 Synergistic mixtures of c6- to c12-alkanedi0ls and tropolone (derivatives) |
| 12/14/2006 | WO2006091852A3 Novel genetic approaches to reduce or inhibit tumorgenicity of human embryonic stem cells and derivatives following transplantation |
| 12/14/2006 | WO2006089422A8 Protein and its use in diagnosing alzheimer's disease |
| 12/14/2006 | WO2006087752A8 Cationic lipids for the transfection of nucleic acids |
| 12/14/2006 | WO2006086545A3 Method to identify novel therapeutics |
| 12/14/2006 | WO2006084249A3 Telomerase rna subunit and methods of use thereof |
| 12/14/2006 | WO2006084179A3 Hiv tat-cd4 hybried molecules and methods of use thereof |
| 12/14/2006 | WO2006081008A3 Nucleic acids for apoptosis of cancer cells |
| 12/14/2006 | WO2006078535A3 Improving embryo development and survival |
| 12/14/2006 | WO2006076628A3 Compositions comprising promoter sequences and methods of use |
| 12/14/2006 | WO2006076094A3 Process for constructing strain having compactin hydroxylation ability |
| 12/14/2006 | WO2006074216A3 Identification of molecular interactions and therapeutic uses thereof |
| 12/14/2006 | WO2006062935A3 Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin |
| 12/14/2006 | WO2006045631A3 Plasmids for gene transfer by bacterial conjugation |
| 12/14/2006 | WO2006017355A3 Improved aprotinin variants |
| 12/14/2006 | WO2006016380A3 A chimeric g protein based rabies vaccine |
| 12/14/2006 | WO2006007444A3 CaMKII/CALCIUM CHANNEL BINDING-RELATED COMPOSITIONS AND METHODS |
| 12/14/2006 | WO2005113571A3 Methods for the delivery of oligomeric compounds |
| 12/14/2006 | WO2005095461A3 Gold-binding protein and use thereof |
| 12/14/2006 | WO2004101751A3 A modified rubisco large subunit ∈n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate |
| 12/14/2006 | WO2003033722A3 Nucleic acid amplification methods |
| 12/14/2006 | WO2001022972A9 Immunostimulatory nucleic acids |
| 12/14/2006 | US20060282922 Expression vector for transforming soybean and controlled transcription of heterologous nucleotide sequences; animal feeds; nutraceuticals |
| 12/14/2006 | US20060282921 Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells |
| 12/14/2006 | US20060282920 Production of antibodies in transgenic plastids |
| 12/14/2006 | US20060282919 Nucleic acid that drives pollen-specific expression; down- or up-regulation of gene expression in pollen; producing a plant with reduced male fertility |
| 12/14/2006 | US20060282917 Modified starch, uses, methods for production thereof |
| 12/14/2006 | US20060282916 Genes controlling plant cell wall formation |
| 12/14/2006 | US20060282915 Soybean event MON89788 and methods for detection thereof |
| 12/14/2006 | US20060282914 Targeted dna insertion in plants |
| 12/14/2006 | US20060282913 Method of efficiently growing modified morning glory plant |
| 12/14/2006 | US20060282912 Production of plants with improved digestibility having an inactive peroxidase |
| 12/14/2006 | US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression |
| 12/14/2006 | US20060282907 Transgenic animal having fatty acid desaturase and method of producing the same |
| 12/14/2006 | US20060281910 Modulating gene expression in crop plants and transforming crop plants that display low transformation efficiencies with existing transformation methods |
| 12/14/2006 | US20060281902 Human signal peptide-containing proteins |
| 12/14/2006 | US20060281901 Method for the production of amyloid-beta peptide using ubiquitin |
| 12/14/2006 | US20060281900 Lepidoptera voltage-gated calcium channels |
| 12/14/2006 | US20060281898 Method for the production of plant seed with modified fibre content and modified seed coat |